CD4 and neoplasm: Notably, except for M0 macrophages, resting dendritic cells, memory CD4+ T cells, activated memory CD4+ T cells, and plasma cells, the low-risk group exhibited more significant differences in immune cell proportions (Fig. 7C), indicating that the immune system of low-risk group patients was more active and more favorable for controlling tumor progression.